Wolf! A Feasibility Study which omitts to mention IRR in the summary is a dog. A study that ommits to mention NPV is a turkey. This study buries both numbers in the fine print.
It is a rare project which is approved with an after-tax IRR of less that 20%.
- Forums
- ASX - By Stock
- Ann: Bibiani Feasibility Study Completed-RSG.AX
Wolf! A Feasibility Study which omitts to mention IRR in the...
-
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RSG (ASX) to my watchlist
|
|||||
Last
64.3¢ |
Change
-0.008(1.15%) |
Mkt cap ! $1.367B |
Open | High | Low | Value | Volume |
64.0¢ | 64.8¢ | 63.5¢ | $745.6K | 1.162M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
26 | 260825 | 64.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
64.5¢ | 121207 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 273238 | 0.640 |
24 | 226798 | 0.635 |
22 | 389281 | 0.630 |
14 | 408090 | 0.625 |
13 | 390386 | 0.620 |
Price($) | Vol. | No. |
---|---|---|
0.645 | 92832 | 17 |
0.650 | 431157 | 14 |
0.655 | 261259 | 16 |
0.660 | 286904 | 9 |
0.665 | 492923 | 6 |
Last trade - 11.02am 25/07/2024 (20 minute delay) ? |
Featured News
RSG (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online